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ABSTRACT 
 
 
 
Phosphate plays a crucial role in biology, owing to the stability of the phosphate ester bond. To 
 
overcome this inherent stability, enzymes that catalyze phosphoryl transfer reactions achieve 
enormous rate accelerations to operate on biologically relevant timescales and the mechanisms 
that underpin catalysis have been the subject of extensive debate. In an archetypal system, β- 
 
phosphoglucomutase catalyzes the reversible isomerization of β-glucose 1-phosphate and 
glucose 6-phosphate via two phosphoryl transfer steps using a β-glucose 1,6-bisphosphate 
intermediate and a catalytic MgII ion. In the present work, a variant of β-phosphoglucomutase, 
where the aspartate residue that acts as a general acid-base is replaced with asparagine, traps 
highly stable complexes containing the β-glucose 1,6-bisphosphate intermediate in the active 
 
site. Crystal structures of these complexes show that, when the enzyme is unable to transfer a 
proton, the intermediate is arrested in catalysis at an initial stage of phosphoryl transfer. The 
nucleophilic oxygen and transferring phosphorus atoms are aligned and in van der Waals contact, 
 
yet the enzyme is less closed than in transition state (analogue) complexes and binding of the 
 
catalytic MgII ion is compromised. Together, these observations indicate that optimal closure and 
 
optimal MgII binding occur only at higher energy positions on the reaction trajectory, allowing 
the enzyme to balance efficient catalysis with product dissociation. It is also confirmed that the 
 
general acid-base ensures that mutase activity is ~103 fold greater than phosphatase activity in β-
phosphoglucomutase. 
 
KEYWORDS 
 
 
phosphoryl transfer enzyme | general acid-base catalysis | near attack conformation | magnesium 
 
ion affinity | X-ray crystallography 
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INTRODUCTION 
 
 
The efficiency of phosphoryl transfer enzymes in overcoming the stability of phosphate mono-
and di-esters under physiological conditions has enabled biology to perform a vast array of 
 
functions, spanning transient cell signaling cascades, energy storage and consumption, protein 
regulation and the manipulation of genetic material (1). Phosphoryl transfer enzymes can achieve 
 
catalytic rate constants (kcat) of greater than 100 s-1, even when spontaneous rate constants are as 
 
low as 10-20 s-1. As such, they possess some of the largest enzymatic accelerations identified, 
 
with catalytic enhancements approaching 1021 (2). Part of these accelerations has often been 
ascribed to general acid-base catalysis that both augments phosphorylation rates by assisting 
deprotonation of the nucleophilic hydroxyl oxygen, and enhances dephosphorylation rates by 
 
aiding protonation of the same oxygen atom (now the bridging oxygen of the phosphate group). 
Residues that satisfy the assignment of the general acid-base (commonly aspartate, glutamate or 
histidine residues) are repeatedly conserved in the active sites of multiple superfamilies of 
phosphoryl transfer enzymes and are consistently identified by mutation studies as key elements 
of enzyme activity (3−8). While structural studies reveal the close proximity of the general acid-
base to reacting groups in near-transition state complexes, the precise relationship of proton 
transfer to the mechanism of the phosphoryl transfer reaction remains uncertain. Density-
functional theory (DFT) models of the phosphoryl transfer step in some enzymes predict that 
 
proton transfer occurs only when there is substantial bond formation between the hydroxyl 
nucleophile and the phosphorus atom (9−13), but conclusions based on DFT models depend on 
how closely the protein conformation reflects that in which proton transfer takes place. However, 
solvent deuterium isotope effect measurements and the pH dependence of pre-steady state kinetic 
analyses often support the DFT models in that the rate of phosphoryl transfer is interpreted to be 
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independent of hydroxyl nucleophile deprotonation (14−16). A resolution of the uncertainty over 
how the proton transfer step contributes to the catalytic cycle requires direct structural evidence 
of the protein conformation in which proton transfer occurs. 
 
 
β-phosphoglucomutase (βPGM) from Lactococcus lactis is a well-studied magnesium-
dependent phosphoryl transfer enzyme of the haloacid dehalogenase (HAD) superfamily (8, 
17−23), which catalyzes the reversible isomerization of β-glucose 1-phosphate (βG1P) and 
 
glucose 6-phosphate (G6P) (Figure 1A). The active site is located in the cleft formed between the 
helical cap domain (T16−V87) and the α/β core domain (M1−D15, S88−K216), with closure of 
the cleft through domain reorientation occurring during catalysis. The active site binds two 
 
phosphate groups, one in the proximal site adjacent to D8 and the catalytic MgII ion, and one in 
the distal site (~8 Å away in the closed enzyme). βPGM transfers a phosphate group from the 
phospho-enzyme (βPGMP, phosphorylated on the carboxylate sidechain of residue D8) to the 
 
physiological substrate, βG1P, (Step 1; (19)) forming an enzyme-bound β-glucose 1,6- 
 
bisphosphate (βG16BP) intermediate (18). Subsequent release of βG16BP to solution permits its 
 
binding in the alternate orientation, leading to dephosphorylation of βG16BP (Step 2; (20)) and 
 
the generation of G6P and βPGMP as products (Figure 1A). In the Step 1 complexes, βPGM 
hydrogen bonds to the substrate directly, whereas in the Step 2 complexes, two water molecules 
mediate hydrogen bonding with substrate (19). Structural investigations of species along the 
reaction coordinate have made extensive use of metal fluoride-based ground and transition state 
 
analogue complexes (24, 25), and have experimentally corroborated the in-line nucleophilic 
attack of phosphoryl transfer, the trigonal bipyramidal nature of the chemical transition state 
(TS), and the requirement for charge balance in the active site (20−22). Moreover, these studies 
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have highlighted how the carboxylate group of the assigned general acid-base (residue D10) can 
 
adopt different orientations (8). In substrate-free βPGM and βPGMP analogue structures (20, 
23), the active site cleft is open and the D10 carboxylate is in the out position (Figure 1B). In 
transition state analogue (TSA) structures (20), domain reorientation has closed the active site 
cleft and the D10 carboxylate is in the in position, where it is positioned to facilitate general 
acid-base catalysis. In the substrate-bound βPGMP analogue structures containing BeF3− (23) two 
 
conformations are observed, in both of which the active site cleft is closed. One has the same 
conformation as the TSA structures, while in the other the cap and core domains have a relative 
rotation of 17° and the D10 carboxylate is in the out position. Both of the substrate-bound 
 
βPGMP analogue structures conform to the criteria of near attack conformations (NACs) (26). 
The TSA-like conformation is termed an aligned NAC as the nucleophile is aligned to attack the 
BeF3− moiety, whereas the rotated conformation is termed a hydrogen-bonded NAC as the 
 
nucleophilic hydroxyl group is hydrogen bonded to the BeF3− moiety (23). The observation of 
 
both NACs supports a model where the conformational change between the two closed forms is 
 
correlated with the out to in transition of D10 and the alignment of the substrate for nucleophilic 
 
attack. 
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Figure 1. The βPGM reaction scheme and change in orientation of residue D10, the assigned 
 
general acid-base. (A) βPGM reaction scheme for the enzymatic conversion of βG1P to G6P 
 
via a βG16BP intermediate. The phosphoryl transfer reaction between the phospho-enzyme 
 
(βPGMP, phosphorylated at residue D8) and βG1P is termed Step 1 and is illustrated with the 
 
transferring phosphate (blue) in the proximal site and the 1-phosphate (red) of βG1P in the distal 
 
site. The equivalent reaction between βPGMP and G6P is termed Step 2 and is shown with the 
transferring phosphate (red) in the proximal site and the 6-phosphate (blue) of G6P in the distal 
site. The two intermediate complexes are labeled βPGM:P6G1P and βPGM:P1G6P to explicitly 
denote the orientation of βG16BP bound in the active site. (B) The carboxylate group of residue 
 
D10 is in the out position in both the open substrate-free βPGMP  analogue structure 
 
(βPGM:BeF3 complex; PDB 2WFA (23); gray carbon atoms) and in the hydrogen bonded NAC 
 
(βPGM:BeF3:G6P complex; PDB 2WF9 (23); magenta carbon atoms). In contrast, the 
 
carboxylate group of residue D10 is in the in position in both the transition state analogue (TSA) 
 
structure (βPGM:MgF3:G6P TSA complex; PDB 2WF5 (20); blue carbon atoms) and in the 
 
aligned NAC (βPGM:BeF3:G6P complex; PDB 2WF8 (23); cyan carbon atoms). Selected active 
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site residues and ligand are shown as sticks in standard CPK colors, with beryllium (light green), 
 
magnesium (green) and fluorine (light blue). Structural waters (red) and the catalytic MgII ion 
(green) are drawn as spheres. Orange dashes indicate hydrogen bonds and black dashes show 
metal ion coordination. 
 
 
 
The models above require extrapolation from the behavior of metal fluoride analogues in the 
active site to that of the substrates. While there is growing computational evidence for a close 
relationship between metal fluoride TSA complexes and the corresponding phosphoryl species 
(27, 28), there are few experimental systems where the properties of both species can be 
examined in detail. In order to address this, we sought to establish a stable enzyme:substrate 
 
complex using an aspartate to asparagine substitution, in a system for which the behavior of 
metal fluoride analogue complexes is well determined (20, 23). Here, we report the properties of 
several complexes involving the βPGM D10N variant (βPGMD10N), which serves as a model of 
 
wild-type βPGM (βPGMWT) with the general acid-base in its protonated form. This variant has 
 
previously been reported to be inactive (8), and was expected to offer the opportunity to study 
 
βPGMP:βG1P, βPGMP:G6P and βPGM:βG16BP complexes independently. Here we show that 
 
the βPGMD10N variant purifies as βPGMD10N:βG16BP complexes. Low-level mutase activity was 
 
observed, which was enhanced once the non-covalently-bound intermediate is removed by 
 
denaturation-refolding. Subsequently, exposure to substrate leads to the reformation of 
 
βPGMD10N:βG16BP complexes in solution, and the trapping of two distinct βPGMD10N:βG16BP 
 
complexes in crystallo, with either the 1- or the 6-phosphate group in the proximal site. In both 
of these complexes, the nucleophilic carboxylate oxygen and the phosphorus atoms are aligned 
and in van der Waals contact, but phosphoryl transfer is arrested by the failure of N10 to release 
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a proton to βG16BP. However, the βPGMD10N:βG16BP complexes do not adopt the fully closed 
conformation of the TSA complexes, indicating that such close proximity between reacting groups is 
insufficient to achieve the architecture used by the enzyme to bind the TS. Remarkably, 
 
the binding affinity of the catalytic MgII ion in the βPGMD10N:βG16BP complexes is reduced 
 
compared to the phospho-enzyme analogue and the TSA complexes, which implies that 
 
antagonism within the coordination of the MgII ion facilitates the release of the high affinity 
 
βG16BP intermediate. 
 
 
 
 
 
EXPERIMENTAL METHODS 
 
 
β-Phosphoglucomutase (βPGM) expression, purification and refolding. Site-directed 
 
mutagenesis (QuikChange II kit, Agilent Technologies) of the βPGM gene from Lactococcus 
 
lactis (EC 5.4.2.6) cloned in a pET22b+ vector was employed to generate the D10N variant 
 
(βPGMD10N) and the D8N variant (βPGMD8N) using primers with single-site base changes and 
 
mutagenesis of the βPGM gene was confirmed by DNA sequencing. Wild-type βPGM 
 
(βPGMWT), βPGMD10N and βPGMD8N proteins were expressed using natural abundance, 15N or 
 
2H15N13C isotopic enrichment (21, 29) and purified using the following methodology which 
 
minimized the presence of contaminating phosphoryl transfer enzymes (e.g., phosphoglucose 
 
isomerase and βPGM from E. coli). The cell pellet was resuspended in ice-cold standard native 
 
buffer (50 mM K+ HEPES (pH 7.2), 5 mM MgCl2, 2 mM NaN3) supplemented with one tablet of 
 
cOmplete™ protease inhibitor cocktail (Roche). The cell suspension was lysed on ice by 
sonication for 5 cycles of pulsation for 20 s with 60 s cooling intervals. The cell lysate was then 
separated by ultracentrifugation (Beckman Coulter Avanti centrifuge) at 24,000 rpm for 35 min 
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at 4 °C. The cleared cell lysate was filtered using a 0.2 µM syringe filter and loaded onto a 
DEAE-Sepharose fast flow ion-exchange column connected to an ÄKTA purification system 
that had been washed previously with 1 column volume of 6 M guanidine hydrochloride, 1 
 
column volume of 1 M NaOH and equilibrated with 5 column volumes of standard native buffer. 
Following extensive washing, proteins bound to the DEAE-Sepharose column were eluted with a 
gradient of 0 to 100% standard native buffer containing 0.5 M NaCl. Fractions containing βPGM 
were checked for purity using SDS-PAGE, were pooled together and concentrated by Vivaspin 
 
(10 kDa MWCO). The protein sample was filtered using a 0.2 µM syringe filter and loaded onto 
a prepacked Hiload 26/60 Superdex 75 size-exclusion column connected to an ÄKTA 
purification system that had been washed previously with 1 column volume of 1 M NaOH and 
 
equilibrated with 5 column volumes of filtered and degassed standard native buffer containing 1 
M NaCl. Fractions containing βPGM were checked for purity using SDS-PAGE, were pooled 
 
together, buffer exchanged into standard native buffer and concentrated to 2 mM by Vivaspin 
(10 kDa MWCO) for storage as 1 mL aliquots at −20 °C. 
 
In contrast to βPGMWT and βPGMD8N, βPGMD10N co-purified with βG16BP as tight, non- 
 
covalently bound βPGMD10N:βG16BP complexes. Substrate-free βPGMD10N was prepared from 
 
the co-purified βPGMD10N:βG16BP complexes using an unfolding-dilution-refolding strategy to 
 
remove βG16BP. Samples of the co-purified βPGMD10N:βG16BP complexes were diluted into 
 
unfolding buffer (4 M guanidine hydrochloride, 50 mM K+ HEPES (pH 7.2), 5 mM MgCl2, 2 
 
mM NaN3), buffer exchanged by Vivaspin (10 kDa MWCO) in unfolding buffer to dilute 
 
βG16BP by 200-fold, and the retained βPGMD10N was refolded by pulse renaturation or dialysis 
 
into standard native buffer. A final buffer exchange to remove any remaining denaturant was 
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performed using a Vivaspin (3 kDa MWCO) and the protein was concentrated to 2 mM for 
 
storage as 1 mL aliquots at −20 °C. Removal of βG16BP from βPGMD10N was confirmed by 31P 
 
NMR spectroscopy in standard NMR buffer (50 mM K+ HEPES (pH 7.2), 5 mM MgCl2, 2 mM 
 
NaN3, 10% (v/v) 2H2O and 1 mM trimethylsilyl propanoic acid (TSP)). 
 
The reconstituted βPGMD10N:βG16BP complexes were formed by the addition of 20 mM 
 
acetyl phosphate (AcP) and 10 mM glucose 6-phosphate (G6P) or 10 mM β-glucose 1-phosphate 
 
(βG1P) to 1 mM substrate-free βPGMD10N in 200 mM K+ HEPES buffer (pH 7.2), 5 mM MgCl2 
 
and 2 mM NaN3. Unbound ligands in the sample (excess G6P, βG1P and AcP) were removed by 
 
buffer exchange into standard NMR buffer. 
 
Reagents. Unless otherwise stated, reagents were purchased from Sigma-Aldrich, GE 
Healthcare, Melford Laboratories or CortecNet. 
βG16BP was isolated from the co-purified βPGMD10N:βG16BP complexes in standard NMR 
 
buffer by heat denaturation of βPGMD10N (2 min at 80 °C), centrifugation at 13,000 rpm to 
 
remove denatured βPGMD10N and filtration of the supernatant containing βG16BP using a 
 
Vivaspin (3 kDa MWCO). Resonance assignments of βG16BP were confirmed by 31P and 
 
natural abundance 1H13C HSQC NMR spectra following the addition of 6 mM EDTA to the 
 
sample. 
 
βG1P was synthesized enzymatically from maltose using maltose phosphorylase (EC 2.4.1.8). 
 
1 M maltose was incubated overnight at 30 °C with 1.5 units mL-1 maltose phosphorylase in 0.5 
 
M phosphate buffer (pH 7.0). βG1P production was confirmed using 31P NMR spectroscopy. 
Maltose phosphorylase (90 kDa) was removed using a Vivaspin (5 kDa MWCO) and the 
resulting flow-through solution containing βG1P was used without further purification. The 
 
concentration of βG1P was measured to be 150 mM by quantitative 31P NMR spectroscopy 
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(recycle time 60 s) against a known concentration of G6P. The concentrations of other 
components in the solution were estimated as follows: 150 mM glucose, 850 mM maltose and 
350 mM inorganic phosphate. 
Uniformly 13C-labeled G6P was synthesized enzymatically from 45 mM uniformly 13C-labeled 
 
D-glucose by incubation for 90 min at 37 °C with 14 units mL-1 hexokinase (EC 2.7.1.1) and 50 
mM ATP in 100 mM Tris-HCl (pH 8.0), 50 mM MgCl2 and 2 mM EDTA. G6P production was 
 
confirmed using 31P NMR spectroscopy. Hexokinase (110 kDa) was removed by denaturation at 
80 °C followed by filtration using a Vivaspin (3 kDa MWCO). The flow-through containing 
uniformly 13C-labeled G6P was used without further purification together with AcP and 
 
substrate-freeβPGMD10N for the formation of uniformly 13C-labeled βG16BP in the reconstituted 
 
βPGMD10N:βG16BP complexes. 
 
Chemically synthesized βG16BP was a gift from Prof. Nicholas Williams, Department of 
Chemistry, The University of Sheffield (30). 
 
NMR spectroscopy. 
 
Instruments and data processing. NMR experiments were acquired at 298 K using Bruker 
spectrometers located at the following institutions: Department of Molecular Biology and 
 
Biotechnology (MBB), The University of Sheffield; School of Chemistry (SC), The University 
of Manchester; Manchester Institute of Biotechnology (MIB), The University of Manchester. 
Experiments were processed using TopSpin (Bruker) or FELIX (Felix NMR, Inc.) and figures 
were prepared using either FELIX or CcpNmr Analysis (31). 1H chemical shifts were referenced 
 
relative to the internal TSP signal resonating at 0.0 ppm and 13C, 15N and 31P chemical shifts 
 
were referenced indirectly using nuclei-specific gyromagnetic ratios. 
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1H15N TROSY spectra. 1H15N TROSY spectra of βPGMWT and substrate-free βPGMD10N 
 
were acquired using 0.5 – 1 mM 15N-βPGM in standard NMR buffer (50 mM K+ HEPES (pH 
 
7.2), 5 mM MgCl2, 2 mM NaN3 with 10% (v/v) 2H2O and 2 mM TSP) containing 50 mM MgCl2. 
 
1H15N TROSY spectra of the βPGMWT:BeF3 and βPGMD10N:BeF3 complexes were acquired 
 
using 0.5 – 1 mM 15N-βPGMWT or 15N-substrate-free βPGMD10N in standard NMR buffer 
 
containing 5 mM BeCl2 and 10 mM NH4F. Experiments were recorded using a Bruker 600 MHz 
 
Avance DRX spectrometer equipped with a TXI cryoprobe and z-axis gradients (MBB) or a 
Bruker 800 MHz Avance I spectrometer equipped with a TXI probe and z-axis gradients (MBB). 
31P spectra. One-dimensional 31P spectra to characterize βG16BP and the βPGMD10N:βG16BP 
 
complexes were acquired using a Bruker 500 MHz Avance DRX spectrometer (operating at 
 
202.456 MHz for 31P) equipped with a broadband probe (MBB). A spectral width of 50 ppm 
 
centered at −10 ppm enabled the observation of the relevant phosphorus signals. Typically, 
accumulations of 10,000 transients without proton-phosphorus decoupling were necessary to 
achieve a sufficient signal-to-noise ratio with sample concentrations in the 0.5 – 1 mM range. 
Spectra were processed with baseline correction and 10 Hz Lorentzian apodization. 
 
31P spectra for kinetic measurements. Reaction kinetics for βPGM-catalyzed reactions were 
followed using a Bruker 500 MHz Avance III HD spectrometer (operating at 202.48 MHz for 
31P) equipped with a Prodigy BBO cryoprobe (SC), which offered significant improvements in 
 
signal sensitivity. One-dimensional 31P spectra without proton-phosphorus decoupling were 
recorded within 1 minute, with 16 transients and a 2 s recycle delay to give signal-to-noise ratios 
 
for 10 mM βG1P of greater than 100:1. The equilibrations of 10 mM βG1P with G6P by 0.1 – 1 
µM βPGMWT, 5 − 50 µM substrate-free βPGMD10N and 10 µM βPGMD8N were measured in 
 
standard kinetic buffer (200 mM K+ HEPES buffer (pH 7.2), 5 mM MgCl2, 2 mM NaN3, 10% 
 
 
 
 
 
12 
Page 13 of 56 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
14 
 
15 
 
16 
 
17 
 
18 
 
19 
 
20 
 
21 
 
22 
 
23 
 
24 
 
25 
 
26 
 
27 
 
28 
 
29 
 
30 
 
31 
 
32 
 
33 
 
34 
 
35 
 
36 
 
37 
 
38 
 
39 
 
40 
 
41 
 
42 
 
43 
 
44 
 
45 
 
46 
 
47 
 
48 
 
49 
 
50 
 
51 
 
52 
 
53 
 
54 
 
55 
 
56 
 
57 
 
58 
 
59 
 
60 
 
 
 
 
 
2H2O and 2 mM TSP). The reaction was initiated by and timed from the addition of 20 mM AcP 
 
and monitored by the acquisition of consecutive 31P spectra. The equilibration of 10 mM βG1P 
with G6P by 5 µM substrate-free βPGMD10N using βG16BP extracted from the co-purified 
 
βPGMD10N:βG16BP complexes as a priming agent was measured in standard kinetic buffer 
 
monitored by one-dimensional 31P spectra recorded without proton-phosphorus decoupling with 
256 transients and a 1 s recycle delay using a Bruker 500 MHz Avance DRX spectrometer 
(MBB). Normalized integral values of both the βG1P and G6P peaks following baseline 
correction and 2 Hz Lorentzian apodization were plotted against time to give kinetic profiles. 
 
The linear steady-state portion of the G6P integral data was fitted using a linear least-squares 
fitting algorithm to derive the catalytic rate constant, kcat. The hydrolysis kinetics of 50 mM AcP 
to inorganic phosphate and acetate by 250 µM βPGM was measured in standard kinetic buffer 
containing 50 mM MgCl2 and 1 mM EDTA. The reaction was timed from the addition of AcP 
 
and monitored by the acquisition of consecutive 31P spectra. Normalized integral values of the 
AcP peak following baseline correction and 2 Hz Lorentzian apodization were plotted against 
time and the rate constant for AcP hydrolysis was derived from linear least-squares fitting of the 
data. A control experiment involving 50 mM AcP alone in standard kinetic buffer established 
that hydrolysis of AcP was insignificant over the same timeframe. Throughout all the kinetic 
 
measurements, the pH of the reactions was found to be invariant as assessed in situ by the 31P 
resonance of inorganic phosphate and the 1H resonances of 200 mM HEPES buffer. 
 
1H13C HSQC and 2D CCH-TOCSY spectra of glucose 1,6-bisphosphate species. Natural 
 
abundance 1H13C HSQC spectra of αG16BP and βG16BP (in 100% 2H2O and 1 mM TSP) were 
 
recorded on a Bruker 500 MHz Avance DRX spectrometer equipped with a TXI probe and z-
axis gradients (MBB) (30). To assign the bound βG16BP resonances in the reconstituted 
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βPGMD10N:βG16BP complexes, 1H13C HSQC and 2D CCH-TOCSY spectra were acquired with 
 
0.5 – 1 mM 15N-labeled substrate-free βPGMD10N in standard NMR buffer containing 20 mM 
 
AcP and 10 mM uniformly 13C-labeled G6P using a Bruker Avance III 800 MHz spectrometer 
 
equipped with a TCI cryoprobe and z-axis gradients (MIB). 
 
1H15N BEST-TROSY experiments. Rapid acquisition 1H15N BEST-TROSY spectra (32, 33) to 
follow βPGMD10N-catalyzed reactions were acquired using 1 mM substrate-free βPGMD10N in 
 
standard kinetic buffer containing either 20 mM AcP or 20 mM AcP and 10 mM βG1P. 1H15N 
BEST-TROSY spectra were recorded using a Bruker 600 MHz Avance DRX spectrometer 
equipped with a TXI cryoprobe and z-axis gradients (MBB) as 6 minute experiments (4 
 
transients, 200 increments and a recycle delay of 0.3 s) with selective 1H pulses centered on the 
amide region (8.7 ppm). Excitation pulses (90°) were 2 ms at 600 MHz (pulse shape Pc9_4) and 
1.7 ms at 600 MHz (pulse shape Eburp2), whereas refocusing pulses (180°) were 1.6 ms at 600 
MHz (pulse shape Reburp). The experimental dead-time was approximately 6 minutes. 
 
Backbone resonance assignment of the βPGMD10N:βG16BP complexes. For the 1H, 13C 
 
and 15N backbone resonance assignment of the reconstituted βPGMD10N:βG16BP complexes, 
 
multi-dimensional heteronuclear NMR spectra were acquired with 0.5 – 1 mM 2H15N13C-labeled 
 
substrate-free βPGMD10N in standard NMR buffer containing 20 mM AcP and 10 mM G6P using 
 
a Bruker 800 MHz Avance III spectrometer equipped with a TCI cryoprobe and z-axis gradients 
 
(MIB). The standard suite of 1H15N-TROSY and 3D TROSY-based constant time experiments 
were acquired (HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, HN(CO)CACB) using 
non-uniform sampling (NUS) with a multi-dimensional Poisson Gap scheduling strategy with 
exponential weighting (34). NUS data were reconstructed using TopSpin3 and multidimensional 
 
decomposition (35). Backbone resonance assignments of the MgII-bound βPGMD10N:P1G6P and 
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MgII-free βPGMD10N:P1G6P complexes present simultaneously in the spectra were obtained 
 
using a simulated annealing algorithm employed by the asstools assignment program (29). 
 
Assignments for the two complexes were confirmed by using 1H15N TROSY spectra of separate 
 
MgII-bound and MgII-free 15N-βPGMD10N:P1G6P complexes, together with sequential backbone 
 
amide to amide correlations obtained from TROSY-based (H)N(COCA)NNH and 
 
H(NCOCA)NNH experiments (36). The MgII-free 15N-βPGMD10N:P1G6P complex was prepared 
 
by dilution of MgII by over 20,000 fold using buffer exchange into standard NMR buffer in the 
 
absence of MgCl2, while the MgII-bound 15N-βPGMD10N:P1G6P complex was prepared in 
 
standard NMR buffer containing 50 mM MgCl2. 
 
Determination of the MgII dissociation constant.  A MgII-free 15N-βPGMD10N:βG16BP 
 
complex was prepared from a reconstituted MgII-bound 15N-βPGMD10N:βG16BP complex by 
 
buffer exchange (3000-fold dilution) and overnight equilibration into standard NMR buffer. A 
 
discontinuous titration of 0 – 47.6 mM MgCl2 into separate MgII-free 15N-βPGMD10N:βG16BP 
 
samples with overnight equilibration was monitored by 1H15N TROSY spectra recorded using a 
Bruker 800 MHz Avance I spectrometer equipped with a TXI probe and z-axis gradients (MBB). 
Peak intensities for well-resolved resonances of the MgII-bound βPGMD10N:βG16BP complex 
 
(residues N10, G11, A115, K117 and I150) were averaged and normalized against the intensity 
of the sidechain Nİ1 resonance of W216, which remains unchanged throughout the titration. The 
dissociation constant (Kd) was obtained by fitting changes in normalized peak intensity as a 
function of MgII concentration to a single-site binding isotherm (37) using a non-linear least 
 
squares fitting algorithm. The solution concentration of MgII present at the beginning of the 
titration was derived from the fitting procedure. 
 
X-ray crystallography. 
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Crystallization and data collection.  Frozen aliquots of substrate-free βPGMD10N or co- 
 
purified βPGMD10N:βG16BP complex in standard native buffer (50 mM K+ HEPES (pH 7.2), 5 
 
mM MgCl2, 2 mM NaN3) were thawed on ice and centrifuged briefly to pellet insoluble material. 
 
Specific ligands were added to a solution of substrate-free βPGMD10N to generate crystals of the 
 
following complexes: βPGMD10N:BeF3  complex  (5 mM BeCl2  and 15 mM NaF), 
 
βPGMD10N:P1G6P and βPGMD10N:P6G1P complexes (15 mM βG1P, 5 mM BeCl2 and 15 mM 
 
NaF) and βPGMD10N:AlF4:G6P complex (10 mM G6P, 5 mM AlCl3 and 20 mM NaF). Crystals 
 
of the βPGMD10N:AlF4:H2O:βG1P complex were obtained from a solution of the co-purified 
 
βPGMD10N:βG16BP complexes containing 5 mM βG1P, 2 mM AlCl3 and 10 mM NH4F. Crystals 
 
of the co-purified βPGMD10N:P1G6P complex were obtained from a solution of the co-purified 
 
βPGMD10N:βG16BP complexes. The solutions were adjusted to a protein concentration of 0.6 
 
mM, were incubated for 1 h and mixed 1:1 with precipitant (24 – 34% (w/v) PEG 4000 or 19 – 
21% (w/v) PEG 3350, 50 − 200 mM Na acetate and 0 − 100 mM Tris (pH 7.5)). Crystals were 
grown at 290 K by hanging-drop vapor diffusion using a 2 µL drop suspended on a siliconized 
 
glass cover slip above a 700 µL well. Thin plate, small needle or rod shaped crystals grew 
typically over several days. Crystals were harvested using a mounted LithoLoop (Molecular 
Dimensions Ltd.) and were either cryo-protected in their mother liquor containing an additional 
25% (v/v) ethylene glycol or excess mother liquor was removed (38) prior to plunging into liquid 
nitrogen. Diffraction data were collected at 100 K on the MX beamlines at the Diamond Light 
 
Source (DLS), Oxfordshire, United Kingdom and on beamline ID14-2 at the European 
Synchrotron Radiation Facility (ESRF), Grenoble, France. 
Data processing, structural determination and refinement. At the DLS, data were 
 
processed using the xia2 pipeline (39), whereas at the ESRF, data were processed with 
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iMOSFLM (40). Resolution cut-offs were applied using either CC-half or by consideration of the 
 
<I/σ(I)> and Rmerge values. All the crystals belonged to the spacegroup P212121, with cell 
 
dimensions that varied depending on the degree of enzyme closure. Structures were determined 
 
by molecular replacement with MolRep (41) using the highest resolution model with the most 
appropriate cap and core domain relationship as a search model. Model building was carried out 
in COOT (42) with ligands not included until the final rounds of refinement using REFMAC5 
(43) so that they could be built into unbiased difference Fourier maps. When structures were 
refined with down-weighted B-factor restraints, the B-factors of the ligands in the resulting 
 
structures were equivalent to those of the surrounding protein, suggesting that the degree of 
accuracy in the placement of the ligand atoms was equivalent to those of the protein atoms. 
Structures with a resolution better than 1.4 Å were refined with anisotropic B-factors. Structure 
 
validation was carried out in COOT and MolProbity (44). Superpositions were carried out using 
PyMOL (45), maps were generated using FFT (46), and domain movements were calculated 
 
using DynDom (47). Additional details for X-ray crystallography data collection, data processing 
and refinement are provided in Table S1 in the Supporting Information. 
Crystallization of the βPGMD10N:P1G6P and the βPGMD10N:P6G1P complexes.  Rod 
 
shaped crystals harvested after 1 week contained predominantly βG16BP in the βPGMD10N 
 
active site, with the 6-phosphate group located in the proximal site and the 1-phosphate group 
bound in the distal site (βPGMD10N:P6G1P complex). After refinement, the ratio of 2Fo − Fc 
 
contour thresholds between the 1- and 6-phosphate groups (ca. 6σ and 5σ, respectively) did not 
correlate with a full βG16BP ligand occupancy in the βPGMD10N:P6G1P complex. When 
modeled at a ligand occupancy of 0.8, B-factor convergence was attained between the βG16BP 
ligand and neighboring residues in the active site, confirming βG16BP as the dominant ligand. 
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Remaining difference map peaks were consistent with the presence of a minor population of 
 
βG1P (with the 1-phosphate in the distal site) but, due to poor connectivity at this resolution, 
 
βG1P was not modeled into the structure. Crystals from the same drop with the same 
morphology harvested after 12 weeks contained only βG16BP bound in the alternate orientation 
with the 1-phosphate group located in the proximal site and the 6-phosphate group bound in the 
distal site (βPGMD10N:P1G6P complex). 
Steady-state kinetic assays.  Steady-state kinetic assays for βPGMWT and substrate-free 
 
βPGMD10N were conducted at 294 K using a FLUOstar OMEGA microplate reader (BMG 
 
Labtech) in 200 mM K+ HEPES buffer (pH 7.2) containing 5 mM MgCl2 and 1 mM NaN3 in a 
 
200 µL reaction volume. The rate of G6P production was measured indirectly using a glucose 6- 
 
phosphate dehydrogenase (G6PDH) coupled assay, in which G6P is oxidized and concomitant 
 
NAD+ reduction is monitored by the increase in absorbance at 340 nm (NADH extinction 
 
coefficient = 6220 M-1 cm-1). βPGMWT and substrate-free βPGMD10N stock concentrations were 
 
determined using a NanoDrop OneC  spectrophotometer (Thermo Scientific) and diluted 
 
accordingly (βPGM extinction coefficient = 19940 M-1 cm-1). For the determination of kcat and 
 
Km values, the reaction was initiated by the addition of 10 mM AcP to solutions of 0.5 mM 
 
NAD+ and 5 units mL-1 G6PDH containing either 5 nM βPGMWT or 500 nM substrate-free 
 
βPGMD10N and variable concentrations of βG1P (5, 15, 35, 50, 70, 100, 160, 230, 330 µM). The 
 
linear steady-state portion of G6P production was fitted using a linear least-squares fitting algorithm 
to determine the reaction velocity (v) at each βG1P concentration. Data were subsequently fitted to 
the standard Michaelis-Menten equation to derive kcat and Km values using 
 
an in-house python non-linear least-squares fitting algorithm. Errors were estimated using a 
 
python bootstrap resampling protocol and are presented at one standard deviation. For the 
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fluoride inhibition experiments monitored using the G6PDH coupled assay, the reaction was 
 
initiated by the addition of 10 mM AcP to solutions of 230 µM βG1P, 0.5 mM NAD+ and 5 units 
 
mL-1 G6PDH containing either 5 nM βPGMWT or 500 nM substrate-free βPGMD10N and variable 
 
concentrations of NaF (0, 1, 2, 3, 5, 7, 10 mM). The linear steady-state portion of G6P 
production was not used for the analysis of fluoride inhibition as βG16BP formation during the 
reaction outcompetes fluoride inhibition (21). The presence of increasing levels of fluoride in the 
reaction buffer extends the lag phase prior to achieving steady-state kinetics, the duration of 
 
which was estimated using a first derivative approach. The time point at which the maximum 
value was reached in the first derivative vs time plot for each reaction containing fluoride was 
normalized against the time point for the reaction in the absence of fluoride. A line of best fit for 
 
the normalized values vs fluoride concentration was determined using a polynomial function. 
 
 
 
 
 
RESULTS 
 
 
Recombinant βPGMD10N co-purifies in complex with βG16BP. βPGMD10N was produced 
 
and purified as for βPGMWT with slight modifications to published procedures (48−50). A 31P 
 
NMR spectrum demonstrated that, unlike βPGMWT, βPGMD10N co-purifies with tightly-bound 
 
phosphorylated glucose ligands (Figure 2A). Four 31P resonances are observed, two with 
chemical shifts corresponding to a 1-phosphate group and two to a 6-phosphate group of glucose. 
The ratio of intensities of the resonances suggests that the phosphate groups are paired, 
consistent with the population of two complexes. Ligand extraction was achieved by the removal 
of heat denatured βPGMD10N (2 min at 80 °C) using centrifugation followed by membrane 
 
filtration of the supernatant. 31P and 1H13C HSQC NMR spectra indicated that a single ligand had 
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been isolated, which revealed that both complexes contained the same phosphorylated glucose 
species (Figure S1 A, C and D and Figure S2B in the Supporting Information). The ligand was 
identified as βG16BP (the reaction intermediate, Figure 1A) by comparison with synthetic α-and 
β-glucose 1,6-bisphosphate species (Figure S1E and Figure S2A). The high affinity of 
βPGMD10N for the βG16BP intermediate is predictable, since kinetic data for βPGMWT has 
 
identified that βG16BP is the tightest binding species of the native substrates, with Km = 0.63 µM 
 
(8) and Km = 0.72 µM (30). Substitution of aspartate with asparagine at residue 10 is likely to 
 
increase the binding affinity of βPGMD10N for βG16BP since the deprotonated D10 sidechain in 
 
βPGMWT does not satisfy charge balance (24) within the complex. Substrate-free βPGMD10N was 
 
prepared from the co-purified βPGMD10N:βG16BP complexes by unfolding the recombinant 
 
protein in 4 M guanidine hydrochloride together with a 200-fold dilution of the ligand using 
buffer exchange and subsequent refolding of βPGMD10N (Figure S1B). A comparison of the 
 
1H15N TROSY spectra of substrate-free βPGMD10N and βPGMWT indicated that βPGMD10N 
 
adopts a native conformation following refolding (Figure S3A). 
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Figure 2. NMR spectra and reaction kinetics of βPGMD10N. (A) 31P spectrum of βPGMD10N 
 
immediately following purification showing four 31P peaks (5.17, 5.08, 2.01 and 1.30 ppm) 
 
 
 
 
(ratio 6:5). Resonances at ~5 ppm and 1−2 ppm correspond to 6-phosphate and 1-phosphate 
 
groups of βG16BP, respectively. (B) Overlay of a section of 1H15N TROSY spectra for a range 
 
of βPGMD10N complexes: (black) substrate-free βPGMD10N; (pink) βPGMD10N:BeF3 complex; 
 
(red) βPGMD10NP − 1H15N BEST-TROSY spectrum started 6 min after addition of 20 mM AcP to 
 
substrate-free βPGMD10N; (gray) substrate-free βPGMD10N − 1H15N BEST-TROSY spectrum 
 
started after a further 92 min by which time AcP has been depleted and βPGMD10NP has reverted 
 
to substrate-free βPGMD10N (the small shift in peak positions is caused by an increase in 
 
inorganic phosphate concentration); (magenta) βPGMD10NP as major species − 1H15N BEST- 
 
TROSY spectrum started 6 min after addition of 10 mM G6P and 20 mM AcP to substrate-free 
 
βPGMD10N; (blue) βPGMD10N:βG16BP complexes − 1H15N BEST-TROSY spectrum started after 
 
a further 145 min by which time AcP has been depleted and the βPGMD10N:βG16BP complexes 
 
dominate in solution. The arrows indicate progression for the assigned residues from (black) 
 
substrate-free βPGMD10N to (magenta) βPGMD10NP to (blue) the βPGMD10N:βG16BP complexes. 
 
(C and D) Michaelis-Menten plots showing the dependence of the reaction velocity (v) for 5 nM 
 
βPGMWT (black circles; n=3) and 500 nM substrate-free βPGMD10N (red circles; n=3) on the 
initial βG1P concentration, monitored using a glucose 6-phosphate dehydrogenase coupled 
assay. Data were fitted to the standard Michaelis-Menten equation to derive kcat and Km values 
 
and the line of best fit is shown for βPGMWT (gray) and substrate-free βPGMD10N (pink). 
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Substrate-free βPGMD10N readily forms a transient phospho-enzyme. βPGMWT can be 
 
phosphorylated to generate βPGMWTP by a number of priming agents, including not only 
 
βG16BP (Figure 1A) but also αG16BP, G6P, and acetyl phosphate (AcP) (17, 30). In order to 
 
establish whether βPGMD10N could be similarly phosphorylated, incubation of 1 mM substrate- 
 
free βPGMD10N with 20 mM AcP was followed using a time course of 1H15N BEST-TROSY 
 
spectra (32, 33) with 6 min time resolution (Figure 2B). The initial spectra overlaid closely with 
 
a 
1 15 P 
 H N TROSY spectrum of the βPGMD10N:BeF3 complex, which is an analogue of βPGMD10N 
 
prepared using conditions described previously for the βPGMWT:BeF3 complex (Figure S3B) 
 
(23). This established that βPGMD10NP is generated during the 6 min dead-time of the time 
 
course. After 98 min, the 1H15N BEST-TROSY spectrum had reverted entirely to that of 
 
substrate-free βPGMD10N. Monitoring the same reaction using 31P NMR spectra, the hydrolysis 
 
rate constant for βPGMD10NP was determined to be 0.020 ± 0.002 s-1 (Figure S3C). The 
 
equivalent rate constant for βPGMWTP under the same conditions is only 3 fold greater (0.060 ± 
 
0.006 s-1), indicating that the proposed general acid-base (D10) has little involvement in the 
 
attack of βPGMP by water. Attempts to crystallize the meta-stable species βPGMD10NP were 
 
unsuccessful. However, the βPGMD10N:BeF3 complex was crystallized and the structure was 
 
determined to 1.3 Å resolution (PDB 5OJZ; Figure 3 A and G, Figure S4A and Table S1). The 
 
cap and core domains were in a predominantly open conformation, as in the βPGMWT:BeF3 
complex (PDB 2WFA (23); non-H atom RMSD = 1.06 Å), and the sidechain of residue N10 was 
in the out position (Figure 1B), thereby not positioned to contribute to the nucleophilic attack of 
 
βPGMD10NP by water. The close similarity of 1H15N TROSY spectra between βPGMWT:BeF3, 
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βPGMD10N:BeF3 and βPGMD10NP indicates that these structural features are common to all three 
 
species in solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Overviews of the active sites and the extent of domain closure in the βPGMD10N 
 
complexes.  The  active  sites  of  (A)  βPGMD10N:BeF3  complex  (PDB  5OJZ),  (B) 
 
βPGMD10N:P1G6P complex (PDB 5OK1), (C) βPGMD10N:AlF4:G6P complex (PDB 5OK2), (D) 
 
co-purified βPGMD10N:P1G6P complex (PDB 5O6P), (E) βPGMD10N:P6G1P complex (PDB 
 
5OK0) and (F) βPGMD10N:AlF4:H2O:βG1P complex (PDB 5O6R). Selected active site residues 
 
and ligands are shown as sticks in standard CPK colors, with beryllium (light green), fluorine 
 
(light blue), aluminum (dark gray), βG16BP (teal carbon atoms; with C1 and C6 labeled for 
 
clarity), G6P (purple carbon atoms) and βG1P (gold carbon atoms). Structural waters (red) and 
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the catalytic MgII ion (green) are drawn as spheres. Orange dashes indicate hydrogen bonds and 
black dashes show metal ion coordination. The extent of domain closure is shown in (G) 
βPGMD10N:BeF3 complex (PDB 5OJZ), (H) βPGMD10N:P1G6P complex (PDB 5OK1) and (I) 
βPGMD10N:AlF4:G6P complex (PDB 5OK2). The protein backbone of βPGMD10N is depicted as 
 
a ribbon, with the core (red) and the cap (green) domains indicated and the ligands shown as sticks 
and spheres (colored as above). The pale gray ribbons indicate the open βPGMWT structure (PDB 
2WHE (20)) and the fully closed βPGMWT:MgF3:G6P TSA complex (PDB 2WF5 (20)) 
superposed on the core domains to show the extent of domain closure in the βPGMD10N 
 
complexes. 
 
 
 
 
The substrate-free βPGMD10N preparation has mutase activity. In addition to substrate- 
 
free βPGMD10N having similar levels of phosphatase activity to βPGMWT, the substrate-free 
 
βPGMD10N  preparation was also found to have mutase activity. The standard glucose 6- 
 
phosphate dehydrogenase coupled assay (8, 17, 18) was used to monitor conversion of βG1P to 
 
G6P using AcP as the priming agent. The kinetic profile displayed the characteristic lag phase 
 
for βPGM (Figure S3 I and J) (30), and a simple steady-state Michaelis-Menten analysis of the 
 
linear portion (Figure 2D), yielded values for kcat of 0.15 ± 0.01 s-1 and Km of 150 ± 12 µM. 
 
Measurements under the same conditions for βPGMWT (Figure 2C), yielded values of 24.5 ± 0.7 
 
s-1 and 92 ± 6 µM, respectively; minor levels of inhibition by the priming agent (17, 30) is a 
 
likely source of the slightly different values determined here compared with some reported 
 
previously for βPGMWT (8, 30). Contaminating E. coli βPGMWT is unlikely to be the source of 
 
mutase activity in the substrate-free βPGMD10N preparation as there is no equilibration of βG1P 
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with G6P over a similar timeframe by βPGMD8N  (Figure S3D), which has identical 
 
chromatography retention characteristics to βPGMD10N. To investigate whether the activity of the 
 
substrate-free βPGMD10N preparation was the result of recovery by acetate (derived from AcP 
 
hydrolysis) substituting for the general acid-base, the equilibration of βG1P with G6P was 
 
primed with βG16BP rather than AcP (Figure S3E). Mutase activity was again observed (with a 
 
slightly larger rate constant, kcat = 0.6 s-1, as there is no inhibition when βG16BP is used as the 
 
priming agent) and thus acetate was not playing a significant role in recovery of activity. In 
 
contrast, it has not been possible to eliminate low levels (~ 0.6%) of contaminating L. lactis 
 
βPGMWT as the source of mutase activity because the measured Km values, and degree of 
 
inhibition by inorganic phosphate (Figure S3F), and by fluoride (Figure S3G) are not sufficiently 
 
different between the substrate-free βPGMD10N  preparation and βPGMWT. Low levels of 
 
βPGMWT can potentially be formed by translational mis-incorporation or by deamidation of 
 
βPGMD10N during refolding, where the N10-G11 sequence will have elevated susceptibility (51). 
 
However, it is difficult to rationalize the dominant effect arising either from translational mis-
incorporation, when an increase in mutase activity is observed following βG16BP removal (kcat = 
 
0.002 s-1 for co-purified βPGMD10N vs kcat = 0.2 s-1 for the substrate-free βPGMD10N 
preparation), or from deamidation, when only a 2-fold increase in activity is observed following 
2 h vs 48 h incubation with 4 M guanidine hydrochloride prior to refolding (Figure S3 K and L). 
 
 
Substrate-free βPGMD10N slowly reforms stable βG16BP complexes. In order to establish 
 
that the substrate-free βPGMD10N preparation was capable of reconstituting the 
 
βPGMD10N:βG16BP complexes in situ, the equilibration of 10 mM βG1P with G6P (and vice 
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versa) by 1 mM substrate-free βPGMD10N in the presence of 20 mM AcP was monitored using a 
 
time course of 1H15N BEST-TROSY spectra with 6 min time resolution (Figure 2B). At this 
concentration of substrate-free βPGMD10N, βG1P and G6P were fully equilibrated (via βG16BP, 
 
Figure 1A) in the 6 min dead-time of the time course, and the initial enzyme species observed 
 
was βPGMD10NP. βPGMD10NP was slowly replaced (kobs = 5 × 10-4 s-1) by two conformationally 
 
distinct species (Figure S5), that reproduce the 31P NMR spectrum of the co-purified 
βPGMD10N:βG16BP complexes (Figure 2A). When 20 mM AcP and 10 mM βG1P were added to 
the reconstituted βPGMD10N:βG16BP complex preparation, the rate constant of equilibration was 
 
within error of that of the original substrate-free βPGMD10N preparation (Figure S3H). 
 
 
 
The nucleophile in the βPGMD10N:P1G6P complex is aligned for attack. The 
 
βPGMD10N:βG16BP complexes were explored using X-ray crystallography to compare their 
 
structures with those of metal fluoride analogue complexes (19, 20, 23). A reconstituted 
 
βPGMD10N:βG16BP complex was crystallized and the structure was determined to 1.9 Å 
resolution (PDB 5OK1; Figure 3 B and H, Figure S4B and Table S1). In this structure, βG16BP 
is bound in a single orientation, with the 1-phosphate in the proximal site and the 6-phosphate in 
the distal site, and is hence termed the βPGMD10N:P1G6P complex. This structure mimics the 
 
active site conformation immediately preceding phosphoryl transfer from βG16BP to βPGM in 
 
Step 2 (Figure 1A). This conformation requires a protonated general acid-base and its surrogate, 
N10, forms a hydrogen bond through its sidechain amide group to the bridging oxygen of the 1-
phosphate of βG16BP. The 1-phosphorus atom is positioned in-line for attack by D8 atom Oį1 
 
(O − P − O angle = 170o) with a donor-acceptor oxygen atom separation of 4.6 Å and a 
nucleophile-phosphorus distance of 3.0 Å, which is inside the sum of the van der Waals radii for 
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these two atoms (3.3 Å) (Figure 3B) (52). The donor-acceptor oxygen atom separation is larger 
 
than is observed in TSA complexes containing AlF4− (3.9 Å; PDB 2WF6) and MgF3− (4.3 Å; 
 
PDB 2WF5 (20)) and in some DFT models of the TS for this chemical step in βPGMWT, (4.2 Å 
 
(11); 4.4 Å (12)). A co-purified βPGMD10N:βG16BP complex was also crystallized and the 
 
structure was determined to 2.2 Å resolution (PDB 5O6P; Figure 3D, Figure S4C and Table S1). In 
this structure, βG16BP is bound in the same orientation as that present in the reconstituted 
βPGMD10N:P1G6P complex and the two complexes overlay closely with a non-H atom RMSD = 
 
0.43 Å (Figure S6 and Table S2). The active site arrangement present in both βPGMD10N:P1G6P 
complexes conforms to the definition of an aligned NAC (23, 26), where atomic distances and 
geometries lie close to those of TS models (25). Given the close similarity between the complexes, 
the structure of the reconstituted βPGMD10N:βG16BP complex will be used in the 
 
comparisons described below. 
 
 
 
The βPGMD10N:P1G6P complex is not fully closed.  In contrast to all deposited metal 
 
fluoride analogue βPGM structures, the alignment of the nucleophile in the βPGMD10N:P1G6P 
 
complex is satisfied without full closure of the enzyme (Figure 3 B and H and Table S2). 
 
Compared to the βPGMWT:MgF3:G6P TSA complex (PDB 2WF5 (20)), the relative orientation 
 
of the cap and core domains undergoes a rotation of 13o, and there are significant changes in the 
hydrogen bonding network within the vicinity of the general acid-base residue. N10 donates a 
hydrogen bond to βG16BP (through atom Nį2), while simultaneously accepting a hydrogen 
bond (through atom Oį1) from the backbone amide NH and the sidechain OH groups of T16. 
 
Crucially, residue T16 dictates the relative degree of closure of the cap and core domains (8, 23), 
 
and in the βPGMD10N:P1G6P complex the conformation of T16 is near the midpoint of the 
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transition between the substrate-free βPGMWT and the βPGMWT:MgF3:G6P TSA structures. The 
 
inference is that van der Waals contact between the attacking nucleophile and the 1-phosphorus 
atom of βG16BP in the βPGMD10N:P1G6P complex, resists a donor-acceptor oxygen atom 
 
separation of less than 4.6 Å, the effect of which propagates through the structure to prevent the 
TS hydrogen bonding organization and full domain closure from being established (11−13, 20). 
 
Moreover, asymmetrical electron density for the catalytic MgII ion in the βPGMD10N:P1G6P 
complex shows clear evidence of a deviation from optimal octahedral coordination geometry 
(Figure S7A), with elongation of distances and distortion of angles, that is not observed in metal 
fluoride-based ground and transition state analogue complexes of βPGM. This result implies that 
a competition exists in MgII ion coordination between the oxygen atom of the 1-phosphate group 
 
of βG16BP (O – MgII = 2.0 Å) and the carboxylate oxyanion of residue D170 (O – MgII = 2.6 
 
Å). The equilibrium position of the MgII ion lies towards coordination by the phosphate oxygen 
atom, which is expected to have a higher anionic charge density, with subsequent compromising 
of coordination by enzymatic oxygen and oxyanion ligands. Together, these observations 
illustrate the interdependency between donor and acceptor atom separation, optimal hydrogen 
 
bond organization, optimal catalytic MgII ion coordination, and full domain closure to achieve 
TS architecture. 
 
 
The βPGMD10N:AlF4:G6P TSA complex is fully closed.  In order to establish that the 
 
antagonism of full closure in the βPGMD10N:P1G6P complex was not simply an artefact of the 
 
aspartate to asparagine substitution, the βPGMD10N:AlF4:G6P TSA complex was crystallized and 
 
the structure was determined to 1.1 Å resolution (PDB 5OK2; Figure 3 C and I, Figure S4D and 
Table S1). This complex superimposes very closely with the βPGMWT:AlF4:G6P TSA complex 
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(PDB 2WF6; non-H atom RMSD = 0.13 Å) and it binds G6P with the 6-phosphate in the distal 
 
site and the square planar AlF4− moiety mimicking the transferring phosphoryl group in the 
 
proximal site between D8 (atom Oį1) and the 1-OH group of G6P (53). The donor-acceptor 
 
distance and angle of alignment are identical to those in the βPGMWT:AlF4:G6P TSA complex 
 
(3.8 Å and 173o, respectively). However, a comparison of the hydrogen bonding arrangements 
between D10/N10 and the 1-oxygen of G6P in the βPGMWT:AlF4:G6P TSA and the 
βPGMD10N:AlF4:G6P TSA complexes reveals a difference in the identity of the proton donor and 
 
proton acceptor. Whereas in the βPGMWT:AlF4:G6P TSA complex, the transferring proton is 
 
bonded to the 1-OH group of G6P and is coordinated by the anionic carboxylate group of the 
general acid-base, the analogous hydrogen bond in the βPGMD10N:AlF4:G6P TSA complex has 
 
the sidechain NH2 group of N10 coordinated by what is likely to be the deprotonated 1-oxygen 
 
of G6P. Owing to the ability of the active site to accommodate the D10 to N10 substitution, the 
βPGMD10N variant is capable of full domain closure with concomitant formation of TS geometry. 
 
 
 
The βPGMD10N:P6G1P complex closely resembles the βPGMD10N:P1G6P complex. While 
 
crystals harvested after 12 weeks consisted exclusively of the βPGMD10N:P1G6P complex, a 
 
crystal with the same morphology harvested from the same drop after only 1 week yielded a 2.2 
 
Å resolution structure of a different complex. While the resolution of the structure was limited, 
the electron density clearly showed that the structure contained βG16BP bound in the alternate 
orientation, with the 6-phosphate in the proximal site and the 1-phosphate in the distal site, and is 
hence termed the βPGMD10N:P6G1P complex (PDB 5OK0; Figure 3E, Figure S4E and Table 
S1). Overall, the orientation of βG16BP does not have a strong influence on the degree of 
domain closure in the βPGMD10N:βG16BP complexes (non-H atom RMSD = 0.34 Å). The 
 
 
 
 
30 
Page 31 of 56 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
14 
 
15 
 
16 
 
17 
 
18 
 
19 
 
20 
 
21 
 
22 
 
23 
 
24 
 
25 
 
26 
 
27 
 
28 
 
29 
 
30 
 
31 
 
32 
 
33 
 
34 
 
35 
 
36 
 
37 
 
38 
 
39 
 
40 
 
41 
 
42 
 
43 
 
44 
 
45 
 
46 
 
47 
 
48 
 
49 
 
50 
 
51 
 
52 
 
53 
 
54 
 
55 
 
56 
 
57 
 
58 
 
59 
 
60 
 
 
 
 
 
relative orientation of the cap and core domains compared to the βPGMD10N:AlF4:G6P TSA 
 
complex have rotations of 13o (βPGMD10N:P1G6P) and 14o (βPGMD10N:P6G1P) (Table S2). The 
 
βPGMD10N:P6G1P complex can again be defined as an aligned NAC (O − P − O angle = 176o, a 
donor-acceptor oxygen atom separation of 4.7 Å and a nucleophile-phosphorus distance of 3.1 Å) 
and the hydrogen bonding of residue N10 is analogous to that present in the βPGMD10N:P1G6P 
complex. There is also a direct hydrogen bond present between the sidechain OH group of S52 and 
the 3-OH group of βG16BP in the βPGMD10N:P6G1P complex, whereas in 
 
the βPGMD10N:P1G6P complex, hydrogen bonding between βG16BP and the protein is mediated 
 
by two water molecules (Figure S8), as observed previously in TSA complexes involving G6P 
and β-glucose 1-phosphonates (19). Hence, alignment of the βG16BP intermediate is achieved in 
both βPGMD10N:βG16BP complexes without full closure of the enzyme. 
 
 
The βPGMD10N:AlF4:H2O:βG1P complex is partially open. The structure of the 
 
βPGMD10N:AlF4:βG1P complex was investigated to ascertain if it behaved analogously to the 
 
βPGMD10N:AlF4:G6P TSA complex, thus providing a direct comparator for the 
 
βPGMD10N:P6G1P complex. The crystal structure of the βPGMD10N:AlF4:βG1P complex was 
 
determined to 1.4 Å resolution (PDB 5O6R; Figure 3F, Figure S4F and Table S1). Surprisingly, 
the structure did not resemble that of the fully closed βPGMWT:AlF4:G6P TSA complex (PDB 
 
2WF6), but instead the protein atoms superimposed almost exactly with the partially open 
 
βPGMD10N:P6G1P complex (non-H atom RMSD = 0.33 Å). Uniquely in βPGM structures, 
 
electron density consistent with a water molecule occupying an axial ligand position of the AlF4− 
 
moiety (instead of the 6-oxygen of βG1P) was present, with D8 still occupying the other axial 
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position, and this structure is hence termed a βPGMD10N:AlF4:H2O:βG1P complex. The water 
 
molecule satisfies the demands of the AlF4− moiety for octahedral coordination while allowing 
 
the cap domain and hydrogen bonding pattern between N10, T16 and D15 to adopt that of the 
 
βPGMD10N:P6G1P complex. The sidechain NH2 group of N10 remains hydrogen bonded to the 
 
6-OH group of βG1P rather than switching to the water molecule, despite the 6-OH group of 
βG1P being located further from D8 (6-OH − Oį1 = 5.7 Å), compared with the 6-oxygen of 
βG16BP in the βPGMD10N:P6G1P structure (6-O – Oį1 = 4.6 Å). This structure implies that 
 
there is greater resistance to the formation of the fully closed βPGMD10N:AlF4− TSA complex 
 
with βG1P than with G6P. In contrast to the apparent deprotonation of the 1-oxygen of G6P in 
the βPGMD10N:AlF4:G6P TSA complex, deprotonation of the 6-OH group of βG1P appears not 
 
to be the preferred arrangement in the βPGMD10N:AlF4:βG1P complex, correlating with the ~3 
 
unit difference in solution pKa values for the two hydroxyl groups (54). 
 
 
 
The βPGMD10N:P1G6P complex dominates in solution. The crystal structures of the 
 
βPGMD10N:βG16BP complexes with the intermediate bound in the two orientations presents a 
 
rationale for the non-equivalent complexes observed in solution using 31P and 1H15N TROSY 
NMR approaches (Figure 2A and Figure S5). In the βPGMD10N:P1G6P complex (Figure 3B), 
there is close proximity between H4 of βG16BP and the imidazole group of residue H20, which 
 
should result in a marked upfield chemical shift change of the H4 resonance through aromatic 
ring current effects. In the βPGMD10N:P6G1P complex (Figure 3E), this chemical shift change 
 
should instead be experienced by the H3 resonance because of the change in orientation of the 
 
βG16BP ligand. To investigate the two βPGMD10N:βG16BP complexes in solution, 1H13C HSQC 
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and CCH-TOCSY spectra were acquired using 1:1 βPGMD10N and 100% U-13C-βG16BP (Figure 
 
S2C). In both βPGMD10N:βG16BP complexes only the H4 resonance of βG16BP is shifted 
 
markedly upfield on binding (Δį = 1.05 and 1.18 ppm), while the H3 resonance of βG16BP is 
 
shifted slightly downfield (Δį = 0.08 and 0.14 ppm). Together, these results indicate that the 
 
bound orientation of βG16BP is the same in the two solution forms, thus identifying both as 
 
βPGMD10N:P1G6P complexes. The dominance of βPGMD10N:P1G6P over βPGMD10N:P6G1P 
 
complexes in solution mirrors the relative dissociation constants for G6P (9 µM) and βG1P (46 
 
µM) in the βPGMWT:AlF4− TSA complexes (19). 
 
 
 
The βPGMD10N:P1G6P complex has weak MgII affinity.  The source of the difference 
 
between the two solution βPGMD10N:P1G6P complexes was investigated using NMR backbone 
 
resonance assignment. All 210 of the non-proline residues were assigned, of which 115 showed 
 
more than one spin system. No significant structural differences were identified upon calculation 
of dihedral angles using TALOS-N (55) (Figure S5 E and F). Residues with the largest chemical 
shift differences between the two complexes were principally located within the active site 
(Figure S5G). For 15N, these comprise L9 (−2.29 ppm), V47 (−2.15 ppm), V141 (−2.78 ppm) 
 
and D170 (−2.16 ppm), for 13C’, N10 (−2.69 ppm) and D170 (−1.74 ppm), for 13Cα, D8 (0.81 
 
ppm), N10 (−0.86 ppm) and S144 (−0.90 ppm), and for 13Cβ, K45 (−0.80 ppm) and S171 (−0.93 
ppm) (Figure S5 A and B). Residues N10 and D170 are involved with the ligation of the catalytic 
MgII ion, suggesting that changes in this coordination may be responsible for the chemical shift 
 
differences observed. To investigate, an MgII-free form of the βPGMD10N:P1G6P complex was 
 
prepared  and  the  1H15N-TROSY  spectrum  corresponded  to  one  of  the  assigned 
 
βPGMD10N:P1G6P complexes, while addition of MgII resulted in the other. Overall, the backbone 
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chemical shift differences between the MgII-bound and MgII-free βPGMD10N:P1G6P complexes 
 
are reminiscent of those between the βPGMWT:MgF3:G6P TSA complex (BMRB 7234 (20)) and 
 
the MgII-bound βPGMD10N:P1G6P complex in terms of the residues involved, but are smaller in 
 
magnitude (Figure S5 C and D). Using changes in 1H15N-TROSY peak intensities on addition of 
 
MgII to the MgII-free βPGMD10N:P1G6P complex, the dissociation constant for MgII binding was 
 
determined to be 7.1 ± 0.6 mM (Figure S7 B and C), consistent with the initial purification of the 
 
βPGMD10N:P1G6P complexes being a mixture of MgII-bound and MgII-free forms in the 
 
presence of 5 mM MgCl2. In contrast, all metal fluoride analogue complexes of βPGM exist in 
 
solution as MgII-bound species at this concentration of MgCl2. The changes in the 31P NMR 
 
chemical shifts between the MgII-bound and MgII-free βPGMD10N:P1G6P complexes (1- 
 
phosphate = +0.71 ppm, 6-phosphate = −0.09 ppm) are small compared with those associated 
 
with protonation of βG1P (−3.4 ppm) or G6P (−3.6 ppm) (Figure 2A and Figure S1 F−K), 
 
indicating that MgII binding is not influenced significantly by protonation of either phosphate 
 
group. Rather, the surprisingly low affinity for MgII at this point on the reaction coordinate 
correlates with its sub-optimal coordination geometry in the structure of the βPGMD10N:P1G6P 
 
complex (Figure S7A), in contrast to the regular MgII coordination geometry observed in the 
 
βPGMD10N:BeF3 and βPGMD10N:AlF4:G6P TSA complex structures. 
 
 
 
 
 
DISCUSSION 
 
 
A unique behavior of the βPGMD10N variant is that, unlike all other forms of βPGM examined 
 
to date, it co-purifies as tight, non-covalently bound βPGMD10N:βG16BP complexes. Effective 
 
removal of the bound βG16BP reaction intermediate required an unfolding-dilution-refolding 
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approach. When challenged with substrate in the presence of excess AcP, the substrate-free 
 
βPGMD10N preparation equilibrates βG1P and G6P, with βPGMD10NP maintained as the primary 
 
enzyme species. On depletion of AcP, the enzyme population shifts slowly to the 
 
βPGMD10N:P1G6P complex becoming the dominant species. In this complex, the 1-phosphate 
group of βG16BP is aligned with the carboxylate oxygen atom of D8, and the sidechain of N10 
is shifted to the in position, where it forms a hydrogen bond with the bridging 1-oxygen atom of 
βG16BP. The enzyme is now caught in the act of phosphoryl transfer, geometrically close to the 
TS, but unable to complete the reaction (or at least overwhelmingly favoring the 1-phosphate 
 
group being bonded to G6P), as N10 will not release the proton hydrogen bonded to the bridging 
oxygen atom. 
 
 
The DFT calculations of βPGMWT reflect enzymatic phosphoryl transfer reactions in general 
 
(25) in that the point at which proton transfer occurs is controversial. Two βPGMWT models 
 
predict that, when D8 attacks βG16BP in Step 2, proton transfer to βG16BP occurs prior to TS 
formation, and in the TS there is a donor to acceptor atom separation of 4.2 Å (11) or 4.4 Å (12). 
 
In a third model, proton transfer is synchronous with TS formation involving a donor to acceptor 
atom separation of 4.0 Å (56), while in a fourth model, proton transfer to βG16BP occurs after 
TS formation, and in the TS there is a donor to acceptor atom separation of 5.0 Å (13). The 
experiment supports the predictions of the first two models, as the βPGMD10N:P1G6P complex 
 
rather than the βPGMD10NP:G6P complex is trapped and, without proton transfer, the donor to 
acceptor atom separation is held at 4.6 Å. Intriguingly, in the 4.4 Å TS model (12), a 
compression of the donor to acceptor atom separation to less than 4.6 Å is associated with the 
start of proton transfer from D10 to βG16BP. Moreover, with the donor to acceptor atom 
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separation being held 0.2 − 0.4 Å greater than that in the TS, the two domains of βPGM do not 
complete their closure. Full closure, including the hydrogen bonding of T16 and N10/D10 found 
in the TS, is only stable when there is compression of the reaction coordinate to below the van 
der Waals contact distance, as mimicked by the TSA complexes (AlF4− = 3.9 Å, PDB 2WF6; 
 
MgF3−  = 4.3 Å, PDB 2WF5 (20)) (Figure 4). Corroboration of the partial closure of the 
 
βPGMD10N complexes is also present in the solution ensembles, where residues of the hinge in 
 
the βPGMD10N:P1G6P complex lie in an intermediate position between the open and the TSA 
 
conformations, and residues D15 and T16 fail to achieve the hydrogen bond arrangement in the 
 
TS model (Figure S9). Together, these observations illustrate the complementarity between the 
TS and the optimal hydrogen bonding of the fully closed enzyme in the TSA conformation, as 
opposed to the partially open ground state βG16BP complex, and thus a means by which the 
enzyme discriminates between the TS (binding it tightly enough to have a sufficiently fast 
chemical step) and product (binding it weakly enough that it does not dissociate too slowly). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A schematic showing the conformational changes required for ground state to 
 
transition state progression in βPGM. Despite van der Waals contact between the attacking 
 
nucleophilic carboxylate oxygen atom of D8 and the 1-phosphorus atom of βG16BP in the 
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ground state βPGMD10N:P1G6P complex (PDB 5OK1), the hydrogen bonding organization of 
the transition state is not attained. A shift in hydrogen bonding partners between T16 and D10 is 
required to allow positional changes in both sidechains, which delivers the protonated general 
acid-base to the bridging oxygen atom of βG16BP. Following proton transfer, further 
 
compression along the donor-acceptor oxygen atom trajectory occurs, establishing the conformation 
of the transition state (model derived from the βPGMWT:MgF3:G6P TSA complex; 
 
PDB 2WF5 (20)). Selected active site residues and ligands are shown as sticks in standard CPK 
 
colors, with a structural water (red) and the catalytic MgII ion (green) drawn as spheres. Large 
translucent spheres represent van der Waals radii for the oxygen and phosphorus atoms of the 
transferring phosphoryl group. 
 
 
 
 
The rate constant for hydrolysis of the phospho-enzyme is almost unaffected by the D10N 
mutation. This result is readily rationalized if hydrolysis occurs with residue 10 in the out 
position, as observed for N10 in the βPGMD10N:BeF3 complex (PDB 5OJZ) and D10 in the 
βPGMWT:BeF3 complex (PDB 2WFA (23)). Previously, it had been proposed that D10 was 
 
engaged in the hydrolysis reaction of βPGMWTP on the basis of a rate acceleration by the mutated 
 
hinge variant βPGMT16P (8). However, this mechanism is not dominant in βPGMWT; the water 
 
molecule that attacks the phosphate group during hydrolysis must at least as readily transfer a 
proton to an ancillary base as to residue 10. The identity of the ancillary base remains to be 
established but the oxygen atoms of the transferring phosphoryl group (via one or more water 
molecules) are strong local candidates. However, the base may be another residue in βPGMWT 
 
(except for residue H20 (8)) or the buffer, via extended hydrogen bonded networks involving 
multiple water molecules. 
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While the βPGMD10NP hydrolysis rate constant cannot be rationalized by a contaminant within 
 
the substrate-free βPGMD10N preparation, βPGMD10N is not unequivocally the source of the 
 
observed mutase activity. However, similarly to the phospho-enzyme hydrolysis reaction, it is 
plausible that proton transfer to the incipient hydroxyl group of G6P or βG1P (as the 1- or 6-
phosphoryl group of βG16BP transfers to residue D8) is delivered from an ancillary acid by a 
water molecule. In a model of the βPGMD10N:P1G6P complex with N10 moved to the out 
 
position (Figure S10), the two water molecules that occupy the space vacated by the sidechain of 
 
N10 comprise part of an extended hydrogen bonded network, involving active site residues H20, 
K76, Y80 and the phosphate group in the distal site, and reaching to bulk solvent. Any one of 
these groups or the buffer (or even potentially the phosphate group in the proximal site) could act 
as the ancillary acid via one or more water molecules, allowing low level mutase activity to 
occur in βPGMD10N. 
 
 
 
 
Regardless of the source of the mutase activity, the replacement of D10 with N10 leads to at 
least a ~350 fold (Figure S3 I and J) reduction in activity. Consequently, the primary effect of 
introducing the general acid-base into βPGMWT is to elevate the rate of substrate turnover to 
 
~103 fold (Figure S3 C and I) greater than the rate of phospho-enzyme hydrolysis, enabling the 
enzyme to discriminate reaction with substrate over reaction with water. This ensures that βPGM 
is primarily a mutase rather than a phosphatase. 
 
 
The co-purified βPGMD10N:βG16BP complexes are present as a near-equimolar mixture of 
 
MgII-bound and MgII-free βPGMD10N:P1G6P complexes in standard NMR buffer (5 mM MgII). 
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This reflects the surprisingly low affinity of these complexes for MgII (Kd = 7.1 mM) compared 
 
with the apparent Km = 270 µM for MgII in the reaction involving βPGMWT (17), and is similar 
 
to the physiological concentration of MgII for L. lactis (~7 mM (57)). The conclusion is that 
 
βG16BP binding leads to a sub-optimally coordinated catalytic MgII ion until full closure is 
 
achieved. More optimal coordination of the catalytic MgII ion is found in structures that include 
the 0.2 − 0.4 Å reduction in donor to acceptor atom separation associated with the formation of 
experimental TSA complexes and in DFT models of the TS. In a different class of phosphoryl 
 
transfer enzymes, the catalytic MgII ion has been identified to play a role in the rate of lid 
opening during the reaction cycle of adenylate kinase (58), as well as reducing non-productive 
active site fluctuations, stabilizing TS architecture, and serving as an anchor to stabilize the 
 
nucleophilic phosphate group. In βPGM, rather than acting as a pivot for opening, it appears that 
 
the catalytic MgII ion is favoring TS binding and disfavoring substrate binding by forming a 
looser association with its ligands as the TS relaxes to ground state complexes. 
 
 
 
CONCLUSIONS 
 
 
The employment of an aspartate to asparagine substitution of the assigned general acid-base of 
 
βPGM allowed the examination of stable enzyme:substrate complexes through the ability of 
 
βPGMD10N  to trap the βG16BP reaction intermediate in situ. Unlike previous structures 
 
determined for substrate, transition state, and product analogue complexes involving βG1P and 
 
G6P, the βG16BP complex achieves both alignment and contact of the attacking nucleophile 
 
with its target but without full closure of the enzyme. This reveals the interplay between 
 
compression of the reaction coordinate to below the van der Waals contact distance and the 
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protein conformation that supports the transition state for the chemical step. The coordination of 
 
the catalytic MgII ion is an important element of this interplay on the one hand by 
complementing the transition state and on the other by facilitating the release of the reaction 
intermediate on an appropriate timescale. 
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